CRISPR-associated (Cas) proteins have revolutionized gene editing by vastly simplifying the insertion of short snippets of new (“donor”) DNA into very specific locations of target DNA. Now, researchers have discovered how the Cas proteins are able to recognize the target locations with such great specificity. Read more »
Global Blood Therapeutics Uses ALS to Tackle Sickle Cell Disease
Sickle cell disease (SCD), which affects millions of people worldwide, has traditionally been treated with a cytotoxic drug that has a range of negative side effects and variable patient response. Bay Area biopharmaceutical company Global Blood Therapeutics (GBT) is on a mission to develop a better treatment and is using the ALS to help. Read more »
Molecular Switch Triggers Bacterial Pathogenicity
Using an array of high-powered x-ray imaging techniques at the ALS, scientists have revealed for the first time the molecular steps that turn on bacteria’s pathogenic genes. The study could open up new avenues in the development of drugs to prevent or treat bacterial infection. Read more »
Shutting Out Ebola and Other Viruses
Researchers have used protein crystallography at the ALS to understand how a drug molecule that has shown some efficacy against Ebola in mice inactivates a membrane protein, called TPC1, used by viruses to infect host cells. Read more »
Exploring the Repeat-Protein Universe
Researchers have published a landmark study that used both crystallography and SAXS to validate computationally designed structures of novel proteins with repeated motifs. The results show that the protein-folding universe is far larger than realized, opening up a wide array of new possibilities for biomolecular engineering. Read more »
Improving Anti-Influenza Medications
Protein crystallography at ALS Beamline 8.3.1 helped scientists understand the M2 proton-channel structure from the influenza A virus, an understanding that is needed to design better anti-influenza medications. Read more »
Foreign DNA Capture during CRISPR–Cas Adaptive Immunity
Using macromolecular crystallography at Beamline 8.3.1 at the ALS, Berkeley researchers discovered how CRISPR/Cas captures foreign DNA for the bacterial immune system. Read more »
Peptoid Nanosheets Offer a Diversity of Functionalities
Researchers at the ALS have recently observed peptoid nanosheets as they self-assemble at an oil–water interface. This development opens the door to designing peptoid nanosheets of increasing complexity and functionality for a broad range of applications, including improved chemical sensors and separators, and safer, more effective drug-delivery vehicles. Read more »
A New Link Between Human and Bacterial Signaling Machinery
Researchers showed that a bacterial signaling protein critical for pathogenesis in Vibrio cholerae is actually a homolog of the human enzyme, cGAS, which detects invading DNA. These results reveal a surprising evolutionary connection between bacterial signaling and human innate immunity. Read more »
Intriguing DNA Editor Has a Structural Trigger
The molecular structures of two proteins from a family of genome-editing enzymes reveal how they target and cleave DNA. The results point the way to the rational design of new and improved versions of the enzymes for basic research and genetic engineering. Read more »
